Skip to main content

Beckman Coulter Acquires Peoples Genetics Technology

NEW YORK, Sept. 10 (GenomeWeb News) -- Beckman Coulter today announced the acquisition of the technologies of Peoples Genetics of Woburn, Mass., in an all-cash transaction.

Financial details were not provided.

The technologies, used for genetic analysis of large pooled populations of individual patient DNAs, include proceedures for sample prepartion and constant denaturant capillary electrophoresis. They were originally developed in a collaboration between MIT and Northeastern University.

Beckman will integrate the acquistion into its CEQ 8000 genetic analysis platform, the company said.

Additionally, William Thilly, former chief geneticist and professor of biological engineering at MIT; and Barry Karger, former CTO of Peoples and a professor of chemistry and director of the Barnett Institute at Northeastern University, will join Beckman as consultants.

Peoples Genetics, based in Woburn, Mass., developed the technology to locate disease-causing gene mutations from extraordinarily large populations. In October 2002 the company received a $2 million grant from the US Department of Commerce's Advanced Technology Program, subsequent to releasing its first-generation edition of its search tool.

 

 

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.